Rodríguez Moreno C, Muro Pascual V, Daviu Pastor A, Bestard Serra M, Llobera Cànaves J, Campoamor Landín F
Unidad de Farmacología Clínica, Gerencia de Atención Primaria, Palma de Mallorca, Baleares.
Aten Primaria. 1996 Mar 31;17(5):309-16.
To analyse the primary care therapeutic approach to urinary tract infections (UTI), and, a secondary objective, to obtain information on the microbiological profile and resistance to antibiotics in this field, with the aim of making therapeutic recommendations.
The UTI diagnosed through systematic checking of sediment and/or culture, requests from health centres are described.
9 Health Centres in Palma (Mallorca) during November 1992.
Out of 2,484 requests for sediment and/or uroculture, clinical history was found in 2,033. At the end there were 232 patients whose request for analysis was for suspected UTI, among whom there were 43 recurring cases, which meant a total of 275 cases.
The most frequent germ was Escherichia coli. 68% had complicated UTI. Empirical treatment was carried out in 60.7%. Treatment of the first episode of UTI was with quinolones in 73.3% of cases, with norfloxacine in 44.1%. There was a higher percentage of resistance of Escherichia coli to cotrimoxazole (49.0%), ampicilline-sulbactam (46.4%), ampicilline (42.0%) and cephalexin (31.4%). In 50 cases there was therapeutic failure, due (among the most commonly used drugs) to norfloxacine in 12.4%, to cotrimoxazole in 28.6%, to norfloxacine in 27.3% and to pipemidic in 18.9%.
There are many more specific than empirical treatments as well as excessive use of drugs not recommended as first choice in primary care. The level of resistance to the new quinolones is considerable and is greater still for some antimicrobial drugs used for UTI.
分析初级保健中治疗尿路感染(UTI)的方法,次要目的是获取该领域微生物学特征及抗生素耐药性信息,以便提出治疗建议。
描述通过系统检查沉淀物和/或培养以及健康中心的请求诊断出的UTI。
1992年11月在帕尔马(马略卡岛)的9个健康中心。
在2484份沉淀物和/或尿培养请求中,2033份有临床病史记录。最终有232例患者的分析请求是疑似UTI,其中43例为复发病例,共计275例。
最常见的病菌是大肠杆菌。68%患有复杂性UTI。60.7%进行了经验性治疗。UTI首次发作的治疗中,73.3%的病例使用喹诺酮类药物,44.1%使用诺氟沙星。大肠杆菌对复方新诺明(49.0%)、氨苄西林 - 舒巴坦(46.4%)、氨苄西林(42.0%)和头孢氨苄(31.4%)的耐药率较高。50例治疗失败,(在最常用药物中)诺氟沙星导致的占12.4%,复方新诺明导致的占28.6%,诺氟沙星导致的占27.3%,吡哌酸导致的占18.9%。
初级保健中特异性治疗比经验性治疗多得多,且过度使用了不推荐作为首选的药物。对新型喹诺酮类药物的耐药水平相当高,对一些用于UTI的抗菌药物的耐药性更高。